CVE-2017-12720

Description

An Improper Access Control issue was discovered in Smiths Medical Medfusion 4000 Wireless Syringe Infusion Pump, Version 1.1, 1.5, and 1.6. The FTP server on the pump does not require authentication if the pump is configured to allow FTP connections.

Category

8.1
CVSS
Severity: High
CVSS 3.0 •
CVSS 2.0 •
EPSS 2.37% Top 20%
Third-Party Advisory securityfocus.com Third-Party Advisory us-cert.gov
Affected: n/a Smiths Medical Medfusion 4000 Wireless Syringe Infusion Pump
Published at:
Updated at:

References

Link Tags
https://ics-cert.us-cert.gov/advisories/ICSMA-17-250-02A third party advisory us government resource
http://www.securityfocus.com/bid/100665 vdb entry third party advisory

Frequently Asked Questions

What is the severity of CVE-2017-12720?
CVE-2017-12720 has been scored as a high severity vulnerability.
How to fix CVE-2017-12720?
To fix CVE-2017-12720, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2017-12720 being actively exploited in the wild?
It is possible that CVE-2017-12720 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~2% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2017-12720?
CVE-2017-12720 affects n/a Smiths Medical Medfusion 4000 Wireless Syringe Infusion Pump.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.